X-FAB Silicon Foundries (XFAB) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
9 Feb, 2026Executive summary
Q4 2025 revenue reached $222.3M, up 18% year-over-year but down 3% sequentially; full-year revenue was $873M, up 7% year-over-year and within guidance.
Core business (automotive, industrial, medical) contributed $814.2M in 2025, up 7% year-over-year and representing 94% of total revenue.
EBITDA for Q4 was $42.3M (19% margin), up 6% year-over-year but down 21% sequentially, impacted by a $9.3M one-off SiC item; full-year EBITDA was $196.8M (22.6% margin).
EBIT for Q4 was $9.8M (4.4% margin), down 7% year-over-year and 59% sequentially; full-year EBIT was $76.4M (8.8% margin).
CEO transition: Damien Macq succeeds Rudi De Winter as of February 2026.
Financial highlights
Q4 gross profit was $41.6M (18.7% margin); full-year gross profit was $184.4M (21.2% margin).
Q4 net income was $1.7M; full-year net income was $30.1M, down from $61.5M in 2024.
Cash and cash equivalents at year-end were $194.3M, up $20.1M sequentially; net debt decreased by $4.5M quarter-over-quarter.
Capex for 2025 was $204.1M, below the initial $250M plan; 2026 capex projected at ~$100M.
Bookings in Q4 2025 were $164.3M, with a book-to-bill ratio of 0.75; backlog stood at $318.2M.
Outlook and guidance
Q1 2026 revenue expected between $190M–$200M, with EBITDA margin of 18–21%.
No full-year 2026 guidance due to macroeconomic uncertainty and limited visibility.
Cost-efficiency measures, including headcount reduction, to yield $6M in quarterly savings by Q4 2026.
Bookings in Q4 2025 understate demand by $30–40M due to shorter cycles, higher yields, and last-time-buy effects.
Long-term growth expected from operational improvements, new design wins, and alignment with electrification and healthcare trends.
Latest events from X-FAB Silicon Foundries
- Q2 revenue fell 9% year-on-year to $205.1M; SiC weakness led to lower guidance, but Q4 rebound expected.XFAB
Q2 20242 Feb 2026 - Q3 revenue up sequentially, China automotive strong, CapEx high, full-year guidance lowered.XFAB
Q3 202418 Jan 2026 - Double-digit growth, major expansions, and $1.5B revenue and 35% margin targeted by 2030.XFAB
Investor Day 202411 Jan 2026 - Three-pillar strategy and $1.1B expansion drive growth in specialty semiconductors.XFAB
CMD 202531 Dec 2025 - Q1 revenue up 8% sequentially, EBITDA margin 24%, guidance and expansion plans reaffirmed.XFAB
Q1 202523 Dec 2025 - 2024 saw revenue and profit declines amid destocking, but recovery and margin gains are expected.XFAB
Q4 202423 Dec 2025 - Q2 revenue up to 8% year-over-year, guidance raised, and capacity expansion completed.XFAB
Q2 202516 Nov 2025 - Q3 revenue up 11% YoY to $229M, with strong medical and industrial growth; order intake fell.XFAB
Q3 20253 Nov 2025